CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer
Fig 5
Gene set enrichment analysis (GSEA) analysis of CKMT1A.
GSEA showed that CKMT1A was associated with (A) inner mitochondrial transmembrane organization; (B) mitochondrial transmembrane transport; (C) NADH metabolic process; and (D) negative regulation of cellular protein catabolic process.